Business
NetworkNewsWire Announces Publication on Innovations Set to Disrupt the Cannabis Industry
New York, New York--(Newsfile Corp. - September 15, 2017) - NetworkNewsWire ("NNW"), a mul...
About this update from Infield Minerals Corp
[{"type":"text","content":"NetworkNewsWire Announces Publication on Innovations Set to Disrupt the Cannabis IndustryNew York, New York--(Newsfile Corp. - September 15, 2017) - NetworkNewsWire (\"NNW\"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids.The publication, titled, \"Biosynthesis Technology Could Transform Cannabinoid Production,\" shines a light on new advances within the cannabis sector. To view the full publication, visit: https://www.networknewswire.com/biosynthesis-technology-transform-cannabinoid-production/ \"InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile), a Vancouver-based biopharmaceutical company, has developed a robust, high-yield biosynthesis process capable of enabling the manufacture of all 90+ naturally-occurring cannabinoids found in the cannabis plant.\"Importantly, the technology could be key in unlocking the minor cannabinoids that are currently economically unfeasible to produce and comprehensively study. The company estimates that its cannabinoid biosynthesis process, a method that's been likened to a 'pharmaceutical copy machine' for its ability to produce bioequivalent compounds.\"About InMed InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed's proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the company.For more information, visit www.inmedpharma.com. About NetworkNewsWireNetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content ...